UK MHRA approves ViiV Healthcare's cabotegravir formulations for HIV-1
The 600mg long-acting injection is the first injectable
treatment for HIV prevention approved in the UK. May 6, 2024. |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.